US Patent 9284380 Anti-ErbB3 antibodies and uses thereof
Patent 9284380 was granted and assigned to Regeneron Pharmaceuticals on March, 2016 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
June 18, 2014
0
Date of Patent
March 15, 2016
0
Patent Applicant
Patent Application Number
14308527
0
Patent Citations Received
Patent Inventor Names
Christopher Daly
0
Douglas MacDonald
0
Xunbao Duan
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9284380 Anti-ErbB3 antibodies and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
